EUVIMEDEUVIMED entdecken
Crossref

Enhancing Mycobacterium tuberculosis-Ag85B immunogenicity by fusing with human Fcγ1 (Ag85B:hFcγ1)

Hamid Bahrami, Arman Mosavat, Saman Soleimanpour, Hadi Farsiani, Narges Valizadeh, Seyed Abdolrahim Rezaee, Abbas Ali Amini

Microbial Pathogenesis · 2025

DOI: 10.1016/j.micpath.2025.107894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Hamid Bahrami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Immunology Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. Hauptthemen laut MEDLINE: Receptors, IgG, Antigens, Bacterial, Mycobacterium tuberculosis, Bacterial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Institute for Medical Research Development, Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, IgGAntigens, BacterialMycobacterium tuberculosisBacterial ProteinsAcyltransferasesTuberculosis VaccinesAnimalsHumansMiceInterferon-gammaRecombinant Fusion ProteinsTuberculosisTh1 CellsImmunoglobulin GImmunoglobulin Fc FragmentsDisease Models, AnimalFemaleInterleukin-17Mice, Inbred BALB CImmunity, CellularAntibodies, BacterialPichiaSaccharomycetales

Stichwörter der Autor:innen

Ag85B:hFcγ1IFN-γImmunogenicityMycobacterium tuberculosisTuberculosis (TB)

Substanzen

Receptors, IgGAntigens, BacterialBacterial ProteinsInterferon-gammaantigen 85B, Mycobacterium tuberculosisRecombinant Fusion ProteinsAcyltransferasesTuberculosis VaccinesImmunoglobulin GImmunoglobulin Fc Fragments

Autor:innen und Institutionen

  • Cancer and Immunology Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Blood Borne Infections Research Center, Academic Center for Education, Culture, and Research (ACECR), Razavi Khorasan, Mashhad, Iran. Electronic address: Mosavat@acecr.ac.ir.
  • Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Immunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Immunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: RezaeeR@mums.ac.ir.
  • Cancer and Immunology Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. Electronic address: abbasali_amini@yahoo.com.

Förderung

  • National Institute for Medical Research Development
  • Mashhad University of Medical Sciences

Zitieren

APA

Bahrami, H., Mosavat, A., Soleimanpour, S., Farsiani, H., Valizadeh, N., Rezaee, S. A., & Amini, A. A. (2025). Enhancing Mycobacterium tuberculosis-Ag85B immunogenicity by fusing with human Fcγ1 (Ag85B:hFcγ1). Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107894

Vancouver

Bahrami H, Mosavat A, Soleimanpour S, Farsiani H, Valizadeh N, Rezaee SA, et al. Enhancing Mycobacterium tuberculosis-Ag85B immunogenicity by fusing with human Fcγ1 (Ag85B:hFcγ1). Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107894

BibTeX
@article{Bahrami2025,
  author = {Bahrami, Hamid and Mosavat, Arman and Soleimanpour, Saman and Farsiani, Hadi and Valizadeh, Narges and Rezaee, Seyed Abdolrahim and Amini, Abbas Ali},
  title = {Enhancing Mycobacterium tuberculosis-Ag85B immunogenicity by fusing with human Fcγ1 (Ag85B:hFcγ1)},
  journal = {Microbial Pathogenesis},
  year = {2025},
  doi = {10.1016/j.micpath.2025.107894}
}
Kostenlos starten →